STOCK TITAN
  1. Home
  2. Sec-filings
  3. XBIO
  4. [ARS] Xenetic Biosciences, Inc. SEC Filing

[ARS] Xenetic Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - Xenetic Biosciences, Inc.

ARS Filing - Xenetic Biosciences, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Xenetic Biosciences, Inc. (XBIO)

Acceptance Date: 2025-10-31T16:30:06.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock XBIO logo
Xenetic Biosciences Inc

NASDAQ:XBIO

XBIO Rankings

#6642 Ranked by Market Cap
N/A Ranked by Dividends

XBIO Latest News

Dec 11, 2025
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
Nov 19, 2025
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
Nov 13, 2025
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
Oct 10, 2025
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
Aug 13, 2025
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results

XBIO Latest SEC Filings

Jan 9, 2026
[8-K] Xenetic Biosciences, Inc. Reports Material Event
Nov 13, 2025
[8-K] Xenetic Biosciences, Inc. Reports Material Event
Nov 12, 2025
[10-Q] Xenetic Biosciences, Inc. Quarterly Earnings Report
Oct 31, 2025
[DEF 14A] Xenetic Biosciences, Inc. Definitive Proxy Statement
Oct 10, 2025
[424B5] Xenetic Biosciences, Inc. Prospectus Supplement (Debt Securities)

XBIO Stock Data

4.77M
2.06M
19.06%
4.6%
1.43%
Biotechnology
Pharmaceutical Preparations
Link
United States
FRAMINGHAM